📜(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-Methoxybenzyl)Phenyl)-6-(Hydroxymethyl)-2-Methoxytetrahydro-2H-Pyran-3,4,5-Triol置于三乙基硅烷,三氟化硼乙醚体系中,用 二氯甲烷,乙腈 用作溶剂,化学反应生成(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-甲氧基苄基)苯基)-6-(羟甲基)四氢-2 参考文献: Processes For The Preparation Of Sglt2 Inhibitors[fr] Procédés De Préparation D'Inhibiteurs De Sglt2 标题: Processes For The Preparation Of Sglt2 Inhibitors[fr] Procédés De Préparation D'Inhibiteurs De Sglt2
专利号:US-8791077-B2 优先权日:2008-05-22 标 题:Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same 发明人:LESLIE BRUCE ROBERT 权利人:LESLIE BRUCE ROBERT; ASTRAZENECA AB 摘要:Methods are provided for treating hyperuricemia, employing an SGLT2 inhibitor alone, or in combination with a supply of carbohydrate, and/or in combination with an inhibitor of uric acid synthesis. Additionally, pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate or an inhibitor of uric acid synthesis or a supply of carbohydrate and an inhibitor of uric acid synthesis are provided in the instant invention and are provided for use in the inventive methods.